Onuki M, Watanabe M, Ishihara N, Suzuki K, Takizawa K, Hirota M, Yamada T, Egawa A, Shibahara O, Nishii M, et al. A partial agonist for retinoid X receptor mitigates experimental colitis. International Immunology. 2019. 31. 4. 251-262
Zai K, Hirota M, Yamada T, Ishihara N, Mori T, Kishimura A, Suzuki K, Hase K, Katayama Y. Therapeutic effect of vitamin D3-containing nanostructured lipid carriers on inflammatory bowel disease. Journal of Controlled Release. 2018. 286. 94-102
Suzuki K, Yamada T, Yamazaki K, Hirota M, Ishihara N, Sakamoto M, Takahashi D, Iijima H, Hase K. Intestinal Epithelial Cell-specific Deletion of α-Mannosidase II Ameliorates Experimental Colitis. Cell Structure and Function. 2018. 43. 1. 25-39
Suzuki K, Aimi T, Ishihara T, Mizushima T. Identification of approved drugs that inhibit the binding of amyloid β oligomers to ephrin type-B receptor 2. FEBS Open Bio. 2016. 6. 5. 461-468
Aimi T, Suzuki K, Hoshino T, Mizushima T. Dextran sulfate sodium inhibits amyloid-β oligomer binding to cellular prion protein. Journal of Neurochemistry. 2015. 134. 4. 611-617